Oppenheimer Asset Management Inc. grew its position in shares of Stericycle Inc (NASDAQ:SRCL) by 22.5% during the first quarter, according to its most recent filing with the SEC. The firm owned 38,543 shares of the business services provider’s stock after acquiring an additional 7,086 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Stericycle were worth $2,098,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the business. BlackRock Inc. grew its stake in shares of Stericycle by 40.9% in the 4th quarter. BlackRock Inc. now owns 7,616,828 shares of the business services provider’s stock worth $279,461,000 after buying an additional 2,210,880 shares during the last quarter. Oregon Public Employees Retirement Fund grew its stake in shares of Stericycle by 6,998.9% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 1,638,209 shares of the business services provider’s stock worth $45,000 after buying an additional 1,615,132 shares during the last quarter. Clarkston Capital Partners LLC grew its stake in shares of Stericycle by 58.2% in the 4th quarter. Clarkston Capital Partners LLC now owns 3,998,885 shares of the business services provider’s stock worth $146,719,000 after buying an additional 1,470,840 shares during the last quarter. Norges Bank purchased a new stake in shares of Stericycle in the 4th quarter worth approximately $41,704,000. Finally, Diamond Hill Capital Management Inc. grew its stake in shares of Stericycle by 250.9% in the 4th quarter. Diamond Hill Capital Management Inc. now owns 818,486 shares of the business services provider’s stock worth $30,030,000 after buying an additional 585,227 shares during the last quarter. Hedge funds and other institutional investors own 96.52% of the company’s stock.
In related news, Director Mark C. Miller sold 260,314 shares of the firm’s stock in a transaction on Tuesday, April 9th. The stock was sold at an average price of $57.18, for a total value of $14,884,754.52. Following the transaction, the director now directly owns 325,848 shares of the company’s stock, valued at approximately $18,631,988.64. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 2.30% of the stock is currently owned by company insiders.
Shares of NASDAQ SRCL traded down $0.91 during midday trading on Wednesday, hitting $48.00. 349,200 shares of the stock traded hands, compared to its average volume of 1,157,220. The stock has a market capitalization of $4.44 billion, a price-to-earnings ratio of 10.79, a PEG ratio of 1.88 and a beta of 1.11. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.02 and a quick ratio of 1.02. Stericycle Inc has a one year low of $34.36 and a one year high of $71.43.
Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Thursday, February 28th. The business services provider reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.07. Stericycle had a positive return on equity of 12.56% and a negative net margin of 8.92%. The firm had revenue of $852.70 million for the quarter, compared to analysts’ expectations of $848.75 million. Equities research analysts anticipate that Stericycle Inc will post 3.34 EPS for the current year.
Several analysts recently weighed in on SRCL shares. Zacks Investment Research upgraded Stericycle from a “sell” rating to a “hold” rating in a research note on Wednesday, May 1st. ValuEngine upgraded Stericycle from a “strong sell” rating to a “sell” rating in a research note on Tuesday, March 5th. Robert W. Baird cut Stericycle from a “neutral” rating to an “underperform” rating and set a $44.00 price objective on the stock. in a research report on Wednesday, April 17th. BidaskClub raised Stericycle from a “sell” rating to a “hold” rating in a research report on Wednesday, February 13th. Finally, Goldman Sachs Group raised Stericycle from a “neutral” rating to a “buy” rating and set a $66.00 price objective on the stock in a research report on Friday, March 1st. Four investment analysts have rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. Stericycle has an average rating of “Hold” and a consensus target price of $59.00.
COPYRIGHT VIOLATION NOTICE: “Stericycle Inc (NASDAQ:SRCL) Shares Bought by Oppenheimer Asset Management Inc.” was reported by Sundance Herald and is owned by of Sundance Herald. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://sundanceherald.com/2019/05/22/stericycle-inc-srcl-shares-bought-by-oppenheimer-asset-management-inc.html.
Stericycle Company Profile
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.
Read More: What is a CD ladder?
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.